Histogenics Corporation (HSGX) Stock Price & Overview

NASDAQ:HSGX

Current stock price

0.162
-0.07 (-30.77%)
At close:
0.1589
0 (-1.91%)
After Hours:

The current stock price of HSGX is 0.162 null. Today HSGX is down by -30.77%. In the past month the price decreased by -28.88%. In the past year, price decreased by -70.28%.

HSGX Key Statistics

52-Week Range0.08 - 1.43
Current HSGX stock price positioned within its 52-week range.
1-Month Range0.15 - 0.29
Current HSGX stock price positioned within its 1-month range.
Market Cap
15.325M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.58
Dividend Yield
N/A

HSGX Stock Performance

Today
-30.77%
1 Week
-26.36%
1 Month
-28.88%
3 Months
-15.27%
Longer-term
6 Months +40.02%
1 Year -70.28%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

HSGX Stock Chart

Histogenics Corporation / HSGX Daily stock chart

HSGX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to HSGX. When comparing the yearly performance of all stocks, HSGX is a bad performer in the overall market: 93.2% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HSGX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to HSGX. The financial health of HSGX is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HSGX Earnings

Next Earnings DateN/A
Last Earnings DateN/A

HSGX Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y96.2%
Revenue Next YearN/A

HSGX Financial Highlights

Over the last trailing twelve months HSGX reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 38.3% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-2.68M
Industry RankSector Rank
PM (TTM) N/A
ROA -83.87%
ROE 30.74%
Debt/Equity -0.79
Chartmill High Growth Momentum
EPS Q2Q%88%
Sales Q2Q%N/A
EPS 1Y (TTM)38.3%
Revenue 1Y (TTM)N/A

HSGX Ownership

Ownership
Inst Owners0.01%
Shares94.60M
Float42.41M
Ins Owners7.79%
Short Float %N/A
Short RatioN/A

About HSGX

Company Profile

Histogenics Corporation is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment. The company is developing NeoCart(R) product to provide treatment in the orthopedic space. Histogenics Corporation is headquartered in Waltham, Massachusetts.

Company Info

Histogenics Corporation

830 WINTER STREET 3RD FLOOR

WALTHAM MA 02451

CEO: Adam Gridley

Phone: 781-547-7900

Histogenics Corporation / HSGX FAQ

What does Histogenics Corporation do?

Histogenics Corporation is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment. The company is developing NeoCart(R) product to provide treatment in the orthopedic space. Histogenics Corporation is headquartered in Waltham, Massachusetts.


What is the stock price of Histogenics Corporation today?

The current stock price of HSGX is 0.162 null. The price decreased by -30.77% in the last trading session.


Does Histogenics Corporation pay dividends?

HSGX does not pay a dividend.


What is the ChartMill rating of Histogenics Corporation stock?

HSGX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Which stock exchange lists HSGX stock?

HSGX stock is listed on the Nasdaq exchange.


What is the ownership structure of Histogenics Corporation (HSGX)?

You can find the ownership structure of Histogenics Corporation (HSGX) on the Ownership tab.